NAB2-STAT6 drives an EGR1-dependent neuroendocrine program in Solitary Fibrous Tumors
C. Hill, A. Indeglia, F. Picone, M. Murphy, C. Cipriano, R. G. Maki, A. Gardini
This study identifies NAB2-STAT6 as a driver of a neuroendocrine program in SFTs through its role in enhancing EGR1 target gene expression.
bioRxiv · Apr 15, 2024Cancer Biology